A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies

ABSTRACT Dengue virus serotype 2 (DENV2) is widespread and responsible for severe epidemics. While primary DENV2 infections stimulate serotype-specific protective responses, a leading vaccine failed to induce a similar protective response. Using human monoclonal antibodies (hMAbs) isolated from deng...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. N. Gallichotte, D. G. Widman, B. L. Yount, W. M. Wahala, A. Durbin, S. Whitehead, C. A. Sariol, J. E. Crowe, A. M. de Silva, R. S. Baric
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2015
Materias:
Acceso en línea:https://doaj.org/article/b00e311a91e041c5b449557878544c2c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b00e311a91e041c5b449557878544c2c
record_format dspace
spelling oai:doaj.org-article:b00e311a91e041c5b449557878544c2c2021-11-15T15:41:31ZA New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies10.1128/mBio.01461-152150-7511https://doaj.org/article/b00e311a91e041c5b449557878544c2c2015-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01461-15https://doaj.org/toc/2150-7511ABSTRACT Dengue virus serotype 2 (DENV2) is widespread and responsible for severe epidemics. While primary DENV2 infections stimulate serotype-specific protective responses, a leading vaccine failed to induce a similar protective response. Using human monoclonal antibodies (hMAbs) isolated from dengue cases and structure-guided design of a chimeric DENV, here we describe the major site on the DENV2 envelope (E) protein targeted by neutralizing antibodies. DENV2-specific neutralizing hMAb 2D22 binds to a quaternary structure epitope. We engineered and recovered a recombinant DENV4 that displayed the 2D22 epitope. DENV2 neutralizing antibodies in people exposed to infection or a live vaccine tracked with the 2D22 epitope on the DENV4/2 chimera. The chimera remained sensitive to DENV4 antibodies, indicating that the major neutralizing epitopes on DENV2 and -4 are at different sites. The ability to transplant a complex epitope between DENV serotypes demonstrates a hitherto underappreciated structural flexibility in flaviviruses, which could be harnessed to develop new vaccines and diagnostics. IMPORTANCE Dengue virus causes fever and dengue hemorrhagic fever. Dengue serotype 2 (DENV2) is widespread and frequently responsible for severe epidemics. Natural DENV2 infections stimulate serotype-specific neutralizing antibodies, but a leading DENV vaccine did not induce a similar protective response. While groups have identified epitopes of single monoclonal antibodies (MAbs), the molecular basis of DENV2 neutralization by polyclonal human immune sera is unknown. Using a recombinant DENV displaying serotype 2 epitopes, here we map the main target of DENV2 polyclonal neutralizing antibodies induced by natural infection and a live DENV2 vaccine candidate. Proper display of the epitope required the assembly of viral envelope proteins into higher-order structures present on intact virions. Despite the complexity of the epitope, it was possible to transplant the epitope between DENV serotypes. Our findings have immediate implications for evaluating dengue vaccines in the pipeline as well as designing next-generation vaccines.E. N. GallichotteD. G. WidmanB. L. YountW. M. WahalaA. DurbinS. WhiteheadC. A. SariolJ. E. CroweA. M. de SilvaR. S. BaricAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 6, Iss 5 (2015)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
E. N. Gallichotte
D. G. Widman
B. L. Yount
W. M. Wahala
A. Durbin
S. Whitehead
C. A. Sariol
J. E. Crowe
A. M. de Silva
R. S. Baric
A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
description ABSTRACT Dengue virus serotype 2 (DENV2) is widespread and responsible for severe epidemics. While primary DENV2 infections stimulate serotype-specific protective responses, a leading vaccine failed to induce a similar protective response. Using human monoclonal antibodies (hMAbs) isolated from dengue cases and structure-guided design of a chimeric DENV, here we describe the major site on the DENV2 envelope (E) protein targeted by neutralizing antibodies. DENV2-specific neutralizing hMAb 2D22 binds to a quaternary structure epitope. We engineered and recovered a recombinant DENV4 that displayed the 2D22 epitope. DENV2 neutralizing antibodies in people exposed to infection or a live vaccine tracked with the 2D22 epitope on the DENV4/2 chimera. The chimera remained sensitive to DENV4 antibodies, indicating that the major neutralizing epitopes on DENV2 and -4 are at different sites. The ability to transplant a complex epitope between DENV serotypes demonstrates a hitherto underappreciated structural flexibility in flaviviruses, which could be harnessed to develop new vaccines and diagnostics. IMPORTANCE Dengue virus causes fever and dengue hemorrhagic fever. Dengue serotype 2 (DENV2) is widespread and frequently responsible for severe epidemics. Natural DENV2 infections stimulate serotype-specific neutralizing antibodies, but a leading DENV vaccine did not induce a similar protective response. While groups have identified epitopes of single monoclonal antibodies (MAbs), the molecular basis of DENV2 neutralization by polyclonal human immune sera is unknown. Using a recombinant DENV displaying serotype 2 epitopes, here we map the main target of DENV2 polyclonal neutralizing antibodies induced by natural infection and a live DENV2 vaccine candidate. Proper display of the epitope required the assembly of viral envelope proteins into higher-order structures present on intact virions. Despite the complexity of the epitope, it was possible to transplant the epitope between DENV serotypes. Our findings have immediate implications for evaluating dengue vaccines in the pipeline as well as designing next-generation vaccines.
format article
author E. N. Gallichotte
D. G. Widman
B. L. Yount
W. M. Wahala
A. Durbin
S. Whitehead
C. A. Sariol
J. E. Crowe
A. M. de Silva
R. S. Baric
author_facet E. N. Gallichotte
D. G. Widman
B. L. Yount
W. M. Wahala
A. Durbin
S. Whitehead
C. A. Sariol
J. E. Crowe
A. M. de Silva
R. S. Baric
author_sort E. N. Gallichotte
title A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
title_short A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
title_full A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
title_fullStr A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
title_full_unstemmed A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
title_sort new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies
publisher American Society for Microbiology
publishDate 2015
url https://doaj.org/article/b00e311a91e041c5b449557878544c2c
work_keys_str_mv AT engallichotte anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT dgwidman anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT blyount anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT wmwahala anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT adurbin anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT swhitehead anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT casariol anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT jecrowe anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT amdesilva anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT rsbaric anewquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT engallichotte newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT dgwidman newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT blyount newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT wmwahala newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT adurbin newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT swhitehead newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT casariol newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT jecrowe newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT amdesilva newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
AT rsbaric newquaternarystructureepitopeondenguevirusserotype2isthetargetofdurabletypespecificneutralizingantibodies
_version_ 1718427723827773440